Literature DB >> 29710095

Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

Kathryn A Phillips1,2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29710095      PMCID： PMC6013401          DOI： 10.1001/jama.2018.4863

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

2.  Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis.

Authors:  Vivek Subbiah; Razelle Kurzrock
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

3.  No Solid Evidence, Only Hollow Argument for Universal Tumor Sequencing: Show Me the Data.

Authors:  Howard Jack West
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

4.  Payer coverage policies for multigene tests.

Authors:  Kathryn A Phillips; Patricia A Deverka; Julia R Trosman; Michael P Douglas; James D Chambers; Christine B Weldon; Andrew P Dervan
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

Review 5.  Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness.

Authors:  O Tan; R Shrestha; M Cunich; D J Schofield
Journal:  Clin Genet       Date:  2018-02-08       Impact factor: 4.438

6.  Genomic sequencing: assessing the health care system, policy, and big-data implications.

Authors:  Kathryn A Phillips; Julia R Trosman; Robin K Kelley; Mark J Pletcher; Michael P Douglas; Christine B Weldon
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301
  6 in total
  9 in total

1.  Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Authors:  Kathryn A Phillips; Patricia A Deverka; Gillian W Hooker; Michael P Douglas
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

2.  Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.

Authors:  Julia R Trosman; Michael P Douglas; Su-Ying Liang; Christine B Weldon; Allison W Kurian; Robin K Kelley; Kathryn A Phillips
Journal:  Value Health       Date:  2020-03-19       Impact factor: 5.725

3.  New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare.

Authors:  K A Phillips; J R Trosman; C B Weldon; M P Douglas
Journal:  JCO Precis Oncol       Date:  2018-11-08

4.  The Global Market for Next-Generation Sequencing Tests Continues Its Torrid Pace.

Authors:  Kathryn A Phillips; Michael P Douglas
Journal:  J Precis Med       Date:  2018-10

5.  Advocacy and actions to address disparities in access to genomic health care: A report on a National Academies workshop.

Authors:  Janet K Williams; Vence L Bonham; Catherine Wicklund; Bernice Coleman; Jacquelyn Y Taylor; Ann K Cashion
Journal:  Nurs Outlook       Date:  2019-06-18       Impact factor: 3.315

6.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

7.  Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling.

Authors:  John Young; Kaustuv Bhattacharya; Sujith Ramachandran; Aaron Lee; John P Bentley
Journal:  Pharmacogenomics J       Date:  2021-02-15       Impact factor: 3.550

8.  The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients.

Authors:  Ariel Hoadley; Sarah Bauerle Bass; Yana Chertock; Jesse Brajuha; Paul D'Avanzo; Patrick J Kelly; Michael J Hall
Journal:  Int J Environ Res Public Health       Date:  2022-02-23       Impact factor: 3.390

9.  Integrating fundamental cause theory and Bourdieu to explain pathways between socioeconomic status and health: the case of health insurance denials for genetic testing.

Authors:  Emily Hammad Mrig
Journal:  Sociol Health Illn       Date:  2020-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.